Top 20 Life Science Startup Investors in Singapore in May 2026
Top 20 Life Science Startup Investors in Singapore in May 2026
| Investor | Life Science Singapore investments |
|---|---|
| EDBI | 2 |
| Eisai | 2 |
| Altara Ventures | 1 |
| KT Investment | 1 |
| Hana Financial Investment | 1 |
| Nestle | 1 |
| Lightstone Ventures | 1 |
| M Capital Partners | 1 |
| The Venture Collective | 1 |
| Anzu Partners | 1 |
| K3 Ventures | 1 |
| SK Securities | 1 |
| Partners Investment | 1 |
| Amgen Ventures | 1 |
| UTEC - The University of Tokyo Edge Capital Partners | 1 |
| Openspace Capital | 1 |
| Temasek Holdings | 1 |
| Seeds Capital | 1 |
| Prox Ventures | 1 |
| KB Financial Group | 1 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.
Show more...Investment focus
- Biotechnology, Software, Health Care
- Series C, Series B, Series D
- United States, Singapore, India
Portfolio highlights
- Paxata — The DataRobot End-of-Life (EOL) policy helps manage product lifecycle phases in a way that is transparent and clear for customers who will seamlessly transition to a new product or service.
- VNLIFE — VNLIFE is a technology company that develops a digital ecosystem for the tourism, logistics, and commerce sector. It enables a full suite of digital products on their payment and service platforms for individual consumers. The company's mission statement is to become the enabler to startups in terms of technical expertise, business guidance,building networks, and capital so as to provide these startups unprecedented opportunity not only to grow their products and services in the domestic market but also to compete in the global arena.
- Iterative Health — Iterative Health is a healthcare technology and services company that focuses on accelerating clinical research to improve patient outcomes through innovative approaches. The company transforms gastrointestinal (GI) care by utilizing AI-driven clinical trials and diagnostics, significantly enhancing access to vital treatments.
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Series A, Series C, Funding Round
- Japan, United States, China
Portfolio highlights
- Seed Therapeutics — SEED Therapeutics designs molecular glue degraders using the full E3 ligase universe to eliminate disease proteins across oncology and beyond.
- Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
- Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts.
Show more...Investment focus
- FinTech, Software, Information Technology
- Series A, Series B, Seed
- Indonesia, Singapore, South Korea
Portfolio highlights
- Buy&Ship — Buyandship provides cross-border eCommerce solution focusing on Marketing and Logistics. At Buyandship, is redefining the experience of E-Commerce without changing the sites, disrupting the underlying infrastructure, we provide consolidate, aggregate and load-balance shipments across the world to the consumer's doorstep. Our technologyfocuses on connecting the fragmented existing logistics infrastructure to create a seamless experience for both merchants and consumers, and the benefit is that they get a solution that is 30-50% less than other carriers. We also work with merchants, marketplaces, and platforms to create a channel to reach an audience across our geographies (9 Countries currently) and reaching over 1.5M+ people per month whilst growing. We envision our members being able to purchase from any site around the world and have it seamlessly be shipped home. No more geographical restrictions, No more price monopolies, No more ambiguous shipping situations. We are building towards a transparent system, where both buyers and sellers just focus on the product.
- Hyper Lounge — Hyperlounge is a startup that has developed a monthly subscription management analysis SaaS by combining management consulting know-how with data collection, analysis and visualization technology. It is a specialized system for small and medium-sized business executives, which is completely different from existing data analysis tools or services.When using this service, user can easily check the core data and analysis necessary for business management every day on mobile without the burden of initial investment or recruitment.
- KYAN Therapeutics — KYAN Therapeutics is a clinical-stage artificial intelligence company leveraging its proprietary technology platforms to transform the way patients are treated and therapies are developed. KYAN is able to revolutionize the drug development and dosage optimization processes and has multiple pipeline combination therapies in development for oncologyand infectious diseases. KYAN de-risks and dramatically accelerates the drug development process, identifying novel combination therapies with unprecedented efficacy and safety. KYAN's clinically-validated platforms are uniquely disease-mechanism and indication agnostic.
KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups andventure companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future.
Show more...Investment focus
- Artificial Intelligence, Software, Machine Learning
- Series A, Series B, Seed
- South Korea, United States, Singapore
Portfolio highlights
- Medipal — Medipal provides personal health for a health consultation. It provides subscription-based personal nurse service for patients.
- Gangnam Unni — Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medicalinformation and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries.The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases.As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
- Healing Paper — Healing Paper is a mobile healthcare and information technology company.
Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services
Show more...Investment focus
- Information Technology, Biotechnology, Software
- Series A, Series B, Funding Round
- South Korea, Singapore, India
Portfolio highlights
- Trustay — Trustay is a real estate asset management company.
- Kimu Studio — Kimu discovers servant artists, plans education and exhibitions with the artist's unique sensibility.
- Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.
Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.
Show more...Investment focus
- Food and Beverage, Health Care, Food Processing
- Grant, Funding Round, Private Equity
- United States, Germany, United Kingdom
Portfolio highlights
- Freshly — Our fully-prepared meals are delivered fresh and ready to eat. We can fuel your dietary preference: plant-based, gluten-free, low calorie, low carb, keto, paleo, and more.
- Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
- Hsu Fu Chi — Hsu Fu Chi is a confectionery company that manufactures various confectionaries, biscuits, chocolates, jellies, sachima, and snacks.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, Ireland, Singapore
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
- Earlens — Earlens is the world's first and only hearing aid solution to directly vibrate the eardrum, delivering a more complete sound than any other hearing aid.
- Claret Medical — Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more...Investment focus
- Health Care, Software, Food and Beverage
- Funding Round, Seed, Series A
- France, United States, Canada
Portfolio highlights
- Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
- Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.
- The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders.
Show more...Investment focus
- Health Care, Biotechnology, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Germany
Portfolio highlights
- SimpliFed — SimpliFed provides virtual breastfeeding and baby feeding support fully covered by your health plan from pregnancy to weaning.
- Concert Bio — Concert Bio helps businesses manage their microbiome. We combine monitoring with analytics to develop interventions that improve the microbiome that matters to you. Our pilot program for CEA growers is currently live and accepting partners, see website for details.
- Infogrid — Infogrid Helps Facilities Management And Estate Owners Deliver Truly Smart Buildings. Our Unique IoT Smart Sensors Can Be Installed In Seconds And Provide Automation And Optimization To Save You Time And Money.
Anzu Partners invests in breakthrough clean tech, industrial, and life science technologies with $1B in assets under management across venture, credit, and public structures.
Show more...Investment focus
- Biotechnology, Software, Manufacturing
- Series A, Series B, Funding Round
- United States, Canada, Spain
Portfolio highlights
- 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
- e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
- CytoTronics — CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.
K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.
Show more...Investment focus
- Financial Services, FinTech, Software
- Series A, Seed, Funding Round
- Singapore, United States, Indonesia
Portfolio highlights
- WIZ.AI — WIZ.AI Talkbot is a leading Generative AI-powered omnichannel customer engagement solution for enterprises to propel business growth.
- iEduGPT — iEduGPT is an AI-powered learning platform based in Singapore that offers personalized, adaptive learning solutions for professional and academic exam preparation. It leverages artificial intelligence to analyze individual learners' strengths and knowledge gaps and create optimized study paths. The platform aims to transform exam preparationby making learning smarter, more efficient, and tailored to each user’s unique needs, covering certifications in finance, academics, and languages.
- Rekosistem — Rekosistem is a Clean- & Climate-Tech Company that enables circular economy implementation in the waste supply chain by leveraging proprietary waste management operation systems to transform waste into recycled materials and renewable resources.
SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.
Show more...Investment focus
- Apps, Health Care, Information Technology
- Series A, Seed, Series B
- South Korea, United States, Singapore
Portfolio highlights
- DSRV — Blockchain infrastructure company DSRV. Providing staking, custody, RPC nodes and Web3 solutions across 170+ protocols.
- Hutom — Reshaping Surgery Through Digital Innovation
- Soft Berry — Soft Berry is an electric vehicle charging platform.
As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- South Korea, United States, Japan
Portfolio highlights
- ASWEMAKE — ASWEMAKE is a shopping app that delivers groceries.
- Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
- Arbor Biotechnologies — Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Using artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, we are accelerating the discovery of proteins for improving human health and sustainability.
Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, Canada, United Kingdom
Portfolio highlights
- Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
- Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.
- Mindset Medical — Mindset Medical is a Health Care Company that develops a platform for clinical information. Through their platform physicians will understand patient pain, saves time for providers and patients, they eliminate paper and redundant forms, and allows providers more time for patients. Mindset Medical was founded in 2016 in Phoenix, Arizona.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Seed, Series A, Funding Round
- Japan, United States, India
Portfolio highlights
- Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
- Aerem — Make the switch to rooftop solar effortlessly with Aerem solution's innovative solar finance and technology solutions. Discover how we're making solar adoption easier than ever before and start saving on your energy costs.
- Power Wave — Power Wave seeks a carbon-neutral world using wave technology for wireless power, tackling global warming and fuel depletion.
Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.
Show more...Investment focus
- E-Commerce, Financial Services, Software
- Series A, Series B, Seed
- Singapore, Indonesia, Philippines
Portfolio highlights
- Igloo — As a top insurtech company, Igloo makes insurance easy across Southeast Asia by working with reputable insurers and distribution partners.
- BrioHR — With our scalable, user-friendly platform, HR is now empowered to play a strategic role and drive company performance.
- Every Half Coffee Roasters — Roasting & Brewing finest quality of specialty coffee bean from Vietnam and the world. We believe that every half bean has its soulmate. Let's find yours
Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Series B, Series C, Series D
- United States, China, India
Portfolio highlights
- Waymo — Waymo stands for a new way forward in mobility. it is a self-driving technology company with a mission to make it safe and easy for people and things to move around.Waymo improves transportation by building software and sensor technology developed in Google’s labs since 2009. In October 2015, they achieved the world’s first fully self-drivingtrip on public roads, in a car without a steering wheel or pedals. They refine Waymo technology through one billion miles of simulation testing each year, and the cars have self-driven over two million miles on public roads across four U.S. cities.It was founded in 2009 and is located in Mountain View, California.
- Glympse Bio — Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
- Black Forest Labs — Black Forest Labs creates advanced generative deep learning models for images and videos. They focus on making these technologies widely accessible and transparent, ensuring that their innovations are easy to use and understand. This approach aims to democratize access to cutting-edge technology and foster greater trust and utility.
Catalysing smart monies into Singapore-based, early-stage technology startups.
Show more...Investment focus
- Software, Biotechnology, Health Care
- Seed, Series A, Funding Round
- Singapore, United States, Hong Kong
Portfolio highlights
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Atomionics — Atomionics is building atomic sensors for navigation and resource exploration. Sensing technology is severely inadequate for a lot of applications navigation and positioning, pinpointing oil and gas reserves, tunnel detection etc. Atomionics builds atomic sensors harnessing quantum mechanical properties of the atoms. This enables measurement ofparameters like gravity, acceleration and rotation with 1000x higher precision and accuracy than the current state of the art, leading to a completely new way of global positioning, and resource exploration.
- Callio Therapeutics — We are advancing next-gen dual-payload ADCs with unique payload and linker tech to deliver dual agents to tumor cells, maximizing benefits for cancer patients.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.
Show more...Investment focus
- Software, Financial Services, SaaS
- Series A, Series B, Seed
- South Korea, India, Vietnam
Portfolio highlights
- Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
- Wavebridge — Wavebridge is a top institutional digital asset company with traditional financial knowhows and crypto finance technology. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
- BlockOdyssey — BlockOdyssey is a tech start-up that provides 'blockchain-based B2B solutions'.Currently, the main solution is supplying 'blockchain-based anti-counterfeiting solution', and logistics & distribution history management is in progress with blockchain. It has received investment from Asia's largest cosmetic company, andis conducting business with French pharmaceutical companies.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!